Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales 2025-10-14 18:02
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration 2025-10-14 18:00
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded 2025-10-14 14:59
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting 2025-10-14 14:26
2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China 2025-10-14 13:44
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14 2025-10-14 12:13
Natural Field Drives Breakthroughs in Co-loading Liposome Technology, Accelerating Upgrading of Raw Materials for Cardiovascular and Gut Health 2025-10-13 23:00
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market 2025-10-13 21:40
Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG 2025-10-13 21:00
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data 2025-10-13 21:00
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain 2025-10-13 21:00
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics 2025-10-13 20:36
Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration 2025-10-13 20:00
Chiron Medical Launches "Early Check, Early Hope" Campaign, Embracing Pink for Breast Cancer Awareness 2025-10-13 19:46
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease 2025-10-13 18:00
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood 2025-10-13 18:00
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025 2025-10-13 16:03
The 138th Canton Fair is Set to Open in Guangzhou on October 15 2025-10-13 14:42
Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies 2025-10-13 14:26
ISTH marks World Thrombosis Day with urgent global call to action 2025-10-13 14:00
1 26 27 28 29 30 1098